$0.18
▼ $-0.02
(-11.33%)
Vol 1.4M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$27.9M
ROE
-271.7%
Margin
-530.8%
D/E
12.44
Beta
1.50
52W
$0–$2
Wall Street Consensus
5 analysts · Apr 20261
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
80.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%
Next Report
May 06, 2026
EPS Estimate: $-0.11
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.11 | — | — |
| Sep 2025 | $-0.09 | $-0.07 | +$0.02 |
| Jun 2025 | $-0.14 | $-0.09 | +$0.05 |
| Mar 2025 | $-0.15 | $-0.17 | $-0.02 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $1.6M | $421K | $3.0M | $2.1M | $21.9M |
| Net Income | — | -$9.5M | -$12.3M | -$8.5M | -$7.4M | $1.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -230.1% | -230.1% | -230.1% | -230.1% | -271.7% | -271.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -287.1% | -469.4% | -469.4% | -469.4% | -530.8% | -530.8% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 14.35 | 14.35 | 14.35 | 14.35 | 12.44 | 12.44 |
| Current Ratio | 1.60 | 1.60 | 1.60 | 1.60 | 1.66 | 1.66 |
Key Ratios
ROA (TTM)
-118.9%
P/S (TTM)
3.92
P/B
3.9
EPS (TTM)
$-0.46
CF/Share
$-1.17
Rev Growth 3Y
-14.7%
52W High
$1.75
52W Low
$0.23
$0.23
52-Week Range
$1.75
Financial Health
Free Cash Flow
-$1.1M
Net Debt
-$22.9M
Cash
$27.1M
Total Debt
$4.2M
As of Dec 31, 2025
How does CUE compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
CUE valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
3.9
▼
69%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
4.0
▲
60%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
CUE profitability vs Biotechnology peers
ROE
-271.7%
▼
304%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-530.8%
▼
85%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-118.9%
▼
155%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
CUE financial health vs Biotechnology peers
D/E ratio
12.4
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.7
▼
63%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲
55%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
CUE fundamentals radar
CUE
Peer median
Industry
CUE profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CUE vs peers: key metrics
Top Holders
Top 5: 17.96%Bleichroeder LP
7.01%
$1.6M
GC Wealth Management RIA, L…
4.76%
$1.1M
Vanguard Group Inc
3.10%
$722K
Lion Point Capital, LP
2.26%
$527K
Geode Capital Management, L…
0.83%
$192K
As of Dec 31, 2025
Latest News
Polymarket removes wagers on U.S. service member rescue mission in Iran
CNBC · Apr 05
Trump confirms both military officers missing in Iran have been rescued
CNBC · Apr 05
More Than 230 Rescued As Devastating Flooding Continues To Hammer Hawaiian Islands
ZeroHedge · Mar 23
3M, Bain Capital To Acquire Madison Fire & Rescue; Forms JV For …
Nasdaq · Mar 19
Another popular barbecue chain files for Chapter 11 bankruptcy
Yahoo Finance · Mar 17